Osama A T El Razaky had completed MD Pediatric at age of 32 years from Tanta University .He had postdoctoral studies in cardiac deformation. He is a head of Egyptian Pediatric Cardiology Association and a member of Egyptian universities promotion committee. He now acts as a professor of Pediatric (Cardiology Unit) in Tanta University. He has published 20 papers in international journal and has been serving as a Reviewer for Acta Pediatric. He was a supervisor of 150 MS and 50 MD theses in Pediatrics. He works as echographer in Pediatrics since 25 years. His main interest in TDI, STI and 3D Strain.

Cardiology, Pediatrics, Diabetes.

Dr. Ellahham has served as Chief Quality Officer for SKMC since 2009. In his role, Dr. Ellahham has led the development of a quality and safety program that has been highly successful and visible and has been recognized internationally by a number of awards. As Chief Quality Officer and Global Healthcare Leader, Dr. Ellahham has a focus on ensuring that that implementation of this best practices leads to breakthrough improvements in clinical quality and patient safety.Dr. Ellahham is a recognized leader in quality, safety, and the use of robust performance improvement in improving healthcare delivery. He serves on a number of US and international committees and advisory bodies. Dr. Ellahham is Certified Professional in Healthcare Quality (CPHQ) by The National Association for Healthcare Quality (NAHQ). He is Certified in Medical Quality (CMQ) by The American Board of Medical Quality (ABMQ). He is the recipient of the Quality Leadership Award from the World Quality Congress and Awards and the Business Leadership Excellence Award from World Leadership Congress in 2015. He is one the nominees for Safe Care magazine Person of the Year in the United States. He is the recipient of SKMC Infection Prevention Award in 2011 and 2012.

Cardiology and its line

Roberto Manfredini, MD, is full professor of Internal Medicine, Director of the Department of Medical Sciences at the University of Ferrara, Italy, and Head of the Clinica Medica Unit, General Hospital of Ferrara, Italy. He has expertise in clinical chronobiology, and he contributed in the identification of rhythmic occurrence of acute cardiovascular diseases along time, eg, hour of the day, day of the week, and month/season of the year. This innovative temporal approach to cardiovascular diseases, i.e., myocardial infarction, acute aortic diseases, pulmonary embolism, stroke, has opened up the potential for improving healthcare via a temporized drug administration (chronotherapy). He has built this innovative knowledge after years of experience in research and teaching both in hospital and education institutions.

Cardiology ,cardiovascular disease

Dr. Hallak is currently Chief of Interventional Cardiology Department at American Hospital Dubai, President (gulf Chapter) of international Society of Endovascular Specialists, Chairman of 4TS international conference, and previous Board Member of Emirate Cardiac Society. Dr. Hallak received his post graduate training and research in United States at University of Illinois, Chicago, North Western University and Louisiana University in New Orleans. He is Board Certified in Interventional Cardiology, Cardiovascular Disease, Vascular Medicine, Endovascular Medicine, Nuclear Cardiology and Internal Medicine. He was the Head of Cardiology Department at Saint Francis Hospital in USA, and assistant Professor at LSU New Orleans and University of West Virginia. He has performed thousands of procedures including Cardiac and Peripheral Vascular Intervention in addition to Pacemaker and ICD/ CRT Implantation. He participated in many national and international research studies with many publications. He involved extensively in local, regional and international cardiology conferences as a Speaker and as a Chairman.

Interventional Cardiology, Cardiovascular Disease, Vascular Medicine, Endovascular Medicine, Nuclear Cardiology and Internal Medicine

Yet to be Updated

cardiomyopathies, heart failure, immunology of cardiovascular disease and an educator.

Carola Förster has a convincing track record in (neuro)physiology with a strong focus on the (dis)functions of the blood-brain barrier (BBB). A significant aspect of her research is related to regulation of gene expression at the BBB, specifically by non-coding RNA, particular microRNA, to offer pharmacological solutions to the observed BBB alterations. For this, CF systematically studies the mechanisms from gene regulation, through transcription, to protein degradation and cellular morphology, linking basic science with clinical aspects. After years of experience in research, evaluation, teaching and administration both in hospital and education institutions, CF developed different in vitro and in vivo models of cerebrovascular disease and established recently a division of computational model to further strengthen this area of research.

heart failure and stroke, neurophysiology

To be updated

..

Bernard Cheung graduated from the University of Cambridge. He was a British Heart Foundation Junior Research Fellow at Cambridge before taking up lectureships in Sheffield and Hong Kong. In 2007-2009, he held the chair in Clinical Pharmacology and Therapeutics in Birmingham. He is currently the Sun Chieh Yeh Heart Foundation Professor in Cardiovascular Therapeutics and heads the Division of Clinical Pharmacology and Therapeutics in the Department of Medicine of the University of Hong Kong. He is an Honorary Consultant Physician of Queen Mary Hospital and the Medical Director of the Phase 1 Clinical Trials Centre. He is the Editor-in-Chief of Postgraduate Medical Journal.

cardiovascular diseases and risk factors, including hypertension and the metabolic syndrome.